Navigation Links
Coimbra Genomics and BGI join forces to conquer stomach cancer
Date:9/30/2013

Cantanhede, Portugal, and Shenzhen, China, September 30, 2013 - China's genomics powerhouse BGI and Portugal-based start-up Coimbra Genomics today announced the initiation of a joint project to unravel the genetic basis of gastric cancer. With an initial budget of over $900k, the project will be one of the first large-scale genomic studies this field, and will involve experts from the IPATIMUP, a leading cancer research institute based in Oporto, Portugal, with a particularly strong track-record on gastric cancer.

"This collaboration forges new ties between BGI and Coimbra Genomics to share and exchange knowledge and research ideas. We expect our join efforts can yield more breakthroughs for better conquering stomach cancer." said Yuan Liu, Europe business development director of BGI Tech, one of BGI's affiliates. "We strongly encourage more European researchers to join us in our efforts to further accelerate the genomic applications in human health, agriculture, bio-energy as well as other innovative research."

Coimbra Genomics CEO and co-founder Nuno Arantes-Oliveira added, "We are delighted to engage with BGI in this pioneering project and hope it becomes a great example of Sino-EU research collaboration to produce excellent science and, above all, to pave the way for new diagnostic and therapeutic solutions for serious diseases."

With almost one million new cases every year, gastric cancer is the second most common cause of cancer death after lung cancer. The disease is particularly common in East and Southeast Asia, as well as in Latin America and parts of Eastern and Southern Europe. The genetic basis of the disease is still poorly understood; early diagnosis is difficult and there is great need for effective treatments.


'/>"/>

Contact: Jia Liu
liujia@genomics.cn
BGI Shenzhen
Source:Eurekalert

Page: 1

Related biology news :

1. SDSCs big data expertise aiding genomics research
2. BGI, University of Helsinki and Wuhan University sign a MOU concerning cooperation on genomics
3. In search for a vaccine, IU biologist receives $2.3 million to explore chlamydia genomics
4. ACRG and BGI report findings from genomics research on recurrent hepatitis B virus integration
5. The genomics symposium to boost the further development of cancer research
6. Elsevier launches new open access journal: Applied and Translational Genomics
7. ShanghaiBio Corporation Partners with Ingenuity Systems to Address Challenges in Analysis and Interpretation of Genomics Data
8. 2 pioneering plant genomics efforts given a funding boost by National Science Foundation
9. Physiological Genomics journal announces a major restructuring
10. New genomics study shows ancestry could help solve disease riddles
11. Ontario Genomics Institute invests in validation of a novel protein interaction technology at U of T
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... July 20, 2017 Delta (NYSE: DAL ) customers ... Delta aircraft at Reagan Washington National Airport (DCA). ... Delta launches biometrics to board aircraft ... Delta,s biometric boarding pass ... is now integrated into the boarding process to allow eligible Delta ...
(Date:6/14/2017)... June 15, 2017  IBM (NYSE: IBM ) is introducing ... event dedicated to developing collaboration between startups and global businesses, ... 15-17. During the event, nine startups will showcase the solutions ... various industries. France ... market, with a 30 percent increase in the number of ...
(Date:5/16/2017)...   Bridge Patient Portal , an enterprise ... EMR Systems , an electronic medical record solutions ... established a partnership to build an interface between ... Centricity™ products, including Centricity Practice Solution (CPS), Centricity ... new integrations will allow healthcare delivery networks using ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... States multicenter, prospective clinical study that demonstrates the accuracy of the FebriDx® ... identifying clinically significant acute bacterial and viral respiratory tract infections by testing ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
Breaking Biology Technology: